Molecular disease map of bone characterizing the postmenopausal osteoporosis phenotype

Journal of Bone and Mineral Research

Volumn 26, Issue 8, 2011, Pages 1793-1801

  Jemtland, Rune ^a   Holden, Marit ^b   Reppe, Sjur ^c   Olstad, Ole K ^c   Reinholt, Finn P ^a,d   Gautvik, Vigdis T ^d   Refvem, Hilde ^e   Frigessi, Arnoldo ^b,d   Houston, Brian ^f   Gautvik, Kaare M ^c,d,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN COMPUTING CENTER   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^f Immunodiagnostics Systems Ltd   (United Kingdom)

Author keywords

arrays; association; bone; gene genetic research; osteoporosis

Indexed keywords

COLLAGENASE 3; DICKKOPF 1 PROTEIN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; SCLEROSTIN; TRANSCRIPTION FACTOR SOX4;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BONE BIOPSY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; ILIAC CREST; LINEAR SYSTEM; MICROARRAY ANALYSIS; MOLECULAR GENETICS; NORWAY; PHENOTYPE; POSTMENOPAUSE OSTEOPOROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

AGING; BIOPSY; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMANS; LIFE STYLE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PHENOTYPE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960653147     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.396     Document Type: Article

References (35)

1. Cummings SR, Melton LJ,. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359: 1761-1767.
2. Kanis JA,. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002; 359: 1929-1936. (Pubitemid 34615775)
3. Johnson ML, Lara N, Kamel MA,. How genomics has informed our understanding of the pathogenesis of osteoporosis. Genome Med. 2009; 1: 84.
4. Kung AW, Huang QY,. Genetic and environmental determinants of osteoporosis. J Musculoskelet Neuronal Interact. 2007; 7: 26-32. (Pubitemid 46730301)
5. Fox KM, Cummings SR, Powell-Threets K, Stone K,. Family history and risk of osteoporotic fracture. Study of Osteoporotic Fractures Research Group. Osteoporos Int. 1998; 8: 557-562. (Pubitemid 28566971)
6. Nguyen T, Sambrook P, Kelly P, et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993; 307: 1111-1115. (Pubitemid 23313207)
7. Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC Jr., Genetic factors in determining bone mass. J Clin Invest. 1973; 52: 2800-2808.
8. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S,. Genetic determinants of bone mass in adults. A twin study. J Clin Invest. 1987; 80: 706-710. (Pubitemid 18003941)
9. Zmuda JM, Sheu YT, Moffett SP,. Genetic epidemiology of osteoporosis: past, present, and future. Curr Osteoporos Rep. 2005; 3: 111-115.
10. Ralston SH, de CB,. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006; 20: 2492-2506. (Pubitemid 44396835)
11. Duncan EL, Brown MA, Sinsheimer J, et al. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res. 1999; 14: 1993-1999. (Pubitemid 30026946)
12. Rowe D, Lichtler A,. A strategy for identifying osteoporosis risk genes. Endocrine. 2002; 17: 67-75. (Pubitemid 34311426)
13. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. Multiple Genetic Loci for Bone Mineral Density and Fractures. N Engl J Med. 2008; 358: 2355-2365. (Pubitemid 351749159)
14. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. New sequence variants associated with bone mineral density. Nat Genet. 2009; 41: 15-17.
15. Hirschhorn JN, Gennari L,. Bona fide genetic associations with bone mineral density. N Engl J Med. 2008; 358: 2403-2405. (Pubitemid 351749169)
16. Zmuda JM, Kammerer CM,. Snipping away at osteoporosis susceptibility. Lancet. 2008; 371: 1479-1480.
17. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH,. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet. 1996; 14: 203-205. (Pubitemid 26338805)
18. Mundy GR,. Nutritional modulators of bone remodeling during aging. Am J Clin Nutr. 2006; 83: 427S-430S. (Pubitemid 44713213)
19. Ralston SH,. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab. 2002; 87: 2460-2466. (Pubitemid 34655301)
20. Richards JB, Rivadeneira F, Inouye M, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008; 371: 1505-1512.
21. Reppe S, Refvem H, Gautvik VT, et al. Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. Bone. 2010; 46: 604-612.
22. Ishwaran H, Rao JS, Kogalur UB,. BAMarray™: Java software for Bayesian analysis of variance for microarray data. BMC Bioinformatics. 2006; 7.
23. Ishwaran H, Rao JS,. Spike and slab gene selection for multigroup microarray data., 100 ed. J Am Stat Assoc. 2005; 100: 764-780. (Pubitemid 41276327)
24. Smyth GK,. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3: Article 3.
25. Smyth GK,. Limma: linear models for microarray data. In:, Gentleman R, Carey V, Dudoit R, Irizarri W, Huber W, eds. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer, 2005: pp. 397-420.
26. Hundrup YA, Hoidrup S, Ekholm O, Davidsen M, Obel EB,. Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: The Danish Nurse Cohort Study. Eur J Epidemiol. 2004; 19: 1089-1095. (Pubitemid 40228497)
27. Deng HW, Mahaney MC, Williams JT, et al. Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol. 2002; 22: 12-25. (Pubitemid 34019889)
28. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 1033-1046. (Pubitemid 47020000)
29. Ferrari S,. Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008; 22: 723-735.
30. Richards JB, Kavvoura FK, Rivadeneira F, et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med. 2009; 151: 528-537.
31. Liu YZ, Dvornyk V, Lu Y, et al. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem. 2005; 280: 29011-29016. (Pubitemid 41161349)
32. Krishnan V, Bryant HU, Macdougald OA,. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006; 116: 1202-1209.
33. Baron R, Rawadi G,. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007; 148: 2635-2643. (Pubitemid 46984775)
34. Truong L, Fazzalari J, Kuliwaba J,. Osteocyte Apoptosis and Expression of Sclerostin in Postmenopausal Women with Fragility Hip Fracture. J Bone Miner Res. 2009; 34 (Suppl1): (Abstract).
35. Huang dW, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4: 44-57.